Profusa, Inc. Receives CE Mark to Market the Lumee Oxygen Platform™ for Continuous, Real-time Monitoring of Tissue Oxygen

First Clinical Application Aimed At Oxygen Monitoring of Compromised Tissues in PAD SOUTH SAN FRANCISCO, Calif., October 3, 2016 — Profusa, Inc., a developer of tissue-integrated biosensors for continuous monitoring of body chemistry, today announced that it received the CE Mark to market its Lumee Oxygen Platform™ for continuous, real-time monitor­ing of tissue oxygen. The … Continue reading Profusa, Inc. Receives CE Mark to Market the Lumee Oxygen Platform™ for Continuous, Real-time Monitoring of Tissue Oxygen